Physician profile
Sameer B Bavishi
NPI 1124231204
$6,913.53
in general payments reported to CMS, 2019-2025
13 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,283 · 2020: $1,629 · 2021: $567 · 2022: $267 · 2023: $1,963 · 2024: $98.36 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098 · Travel and Lodging: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.32 |
| Travel and Lodging | $1,069.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,686.82 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $2,506.61 | 2019-2023 | Comprehensive Shoulder System, Identity, Choice Instruments |
| Crossroads Orthopedics, LLC | $399.43 | 2021-2024 | |
| Orthofix Medical, INC. | $82.89 | 2023-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $52.73 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $51.15 | 2019-2024 | Euflexxa |
| Cumberland Pharmaceuticals, INC. | $30.65 | 2025 | Vibativ |
| Djo, LLC | $23.68 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.24 | 2025 | |
| Stryker Corporation | $16.50 | 2019 | |
| Integra Lifesciences Corporation | $14.89 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.57 | 2019 | |
| Amgen INC. | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Bavishi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.